Incidence and Trend of Type I and II Endometrial Cancer in Women from Two Population-Based European Cancer Registries (1998-2012).

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601 (Electronic) Linking ISSN: 16604601 NLM ISO Abbreviation: Int J Environ Res Public Health Subsets: MEDLINE

Original Publication: Basel : MDPI, c2004-

Endometrial Neoplasms*/epidemiology; Cohort Studies ; Female ; Humans ; Incidence ; Registries ; Spain/epidemiology

Endometrial cancer (EC) is the most frequent female genital tract cancer in Europe. This cohort study aimed to determine age-standardised incidence rates and long-term trends of type I and II endometrial cancer in women from population-based cancer registries in the Region of Murcia (Spain) and the Bas-Rhin area (France). Data of new cases of endometrial cancer between 1998 and 2012 were obtained from the Murcia and Bas-Rhin cancer registries. In that period, 3756 cases of endometrial cancer were recorded, with 3270 corresponding to type I EC and 486 corresponding to type II EC. The Bas-Rhin area presented higher age-adjusted incidence rates than those in the Region of Murcia for both type I EC (24.2 and 19.3 cases/100,000 person-years (py), respectively) and type II EC (4.4 and 2.3 cases/100,000 py, respectively). Joinpoint regression showed no changes in trends. In both populations, there was an increasing trend for both EC types, but the trend was steeper in the Region of Murcia and larger overall for type II EC. Finally, a significant increase was observed in the annual trend of type II EC. Further studies are warranted to determine the potential risk factors, and continued efforts are needed to improve the recording and monitoring of EC types.

Eur J Cancer. 2015 Oct;51(15):2191-2205. (PMID: 26421822)
J Natl Cancer Inst. 2018 Apr 1;110(4):354-361. (PMID: 29045681)
Br J Cancer. 2011 Apr 26;104(9):1505-10. (PMID: 21522151)
JAMA. 2002 Jul 17;288(3):321-33. (PMID: 12117397)
Endocr Relat Cancer. 2000 Dec;7(4):227-42. (PMID: 11174845)
Stat Med. 2000 Feb 15;19(3):335-51. (PMID: 10649300)
Eur J Obstet Gynecol Reprod Biol. 2013 Feb;166(2):209-14. (PMID: 23176760)
Ann Oncol. 2010 May;21 Suppl 3:iii3-13. (PMID: 20427357)
Am J Epidemiol. 2012 Aug 15;176(4):269-78. (PMID: 22831825)
Br J Cancer. 2004 May 4;90(9):1756-9. (PMID: 15208619)
Int J Obes (Lond). 2015 Feb;39(2):189-98. (PMID: 24909829)
Med Clin (Barc). 2016 Oct 7;147(7):287-92. (PMID: 27423654)
J Clin Oncol. 2013 Jul 10;31(20):2607-18. (PMID: 23733771)
Lancet Oncol. 2015 Sep;16(9):1061-1070. (PMID: 26254030)
Eur J Epidemiol. 2015 May;30(5):397-412. (PMID: 25800123)
F1000Res. 2019 Jun 12;8:. (PMID: 31231511)
Cancer Causes Control. 2000 Feb;11(2):185-92. (PMID: 10710204)
Cancer Causes Control. 2007 Nov;18(9):967-88. (PMID: 17638104)
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3119-30. (PMID: 21030602)
Cancer Causes Control. 2010 Nov;21(11):1851-6. (PMID: 20628804)
Eur J Cancer. 2015 Jun;51(9):1164-87. (PMID: 24120180)
Semin Oncol Nurs. 2019 Apr;35(2):157-165. (PMID: 30867105)
Obstet Gynecol. 2009 Dec;114(6):1197-1204. (PMID: 19935019)
Clin Transl Oncol. 2017 Jul;19(7):799-825. (PMID: 28093701)
Cancer. 2006 Jun 1;106(11):2376-81. (PMID: 16639730)
Lancet. 2005 Apr 30-May 6;365(9470):1543-51. (PMID: 15866308)
Womens Health (Lond). 2012 Mar;8(2):169-89. (PMID: 22375720)
Front Surg. 2021 Nov 30;8:790152. (PMID: 34917648)
Gynecol Oncol. 2017 Aug;146(2):359-367. (PMID: 28545689)
Clin Transl Oncol. 2018 Feb;20(2):201-211. (PMID: 28718071)
Int J Gynecol Cancer. 2014 Mar;24(3):384-93. (PMID: 24463639)

Keywords: Europe; endometrial cancer; incidence; trends

Date Created: 20220412 Date Completed: 20220413 Latest Revision: 20220513

20250114

PMC8997612

10.3390/ijerph19073789

35409473